Rivals chase Bristol-Myers in cancer immu**therapy drug race
 

Rivals chase Bristol-Myers in cancer immu**therapy drug race
LONDON (Reuters) - Bristol-Myers Squibb has pulled ahead in the race to dominate the hot new cancer immu**therapy market but Merck & Co, Roche and AstraZeneca still have important opportunities to close the gap.
http://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...3Q:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...3Q:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/dQXQx88_04U